Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD INQUIRY INTO "ONE-STEP" PREGNANCY TEST CLAIMS

This article was originally published in The Tan Sheet

Executive Summary

NAD INQUIRY INTO "ONE-STEP" PREGNANCY TEST CLAIMS made by three companies, Johnson & Johnson's Advanced Care Products division, Becton Dickinson and Quidel, resulted in assurances by the companies that future claims will take into consideration concerns expressed by the National Advertising Division (NAD) of the Counsel of Better Business Bureaus. NAD investigated claims made for the firms' home pregnancy tests at the prompting of Warner-Lambert, marketer of the e.p.t. one-step Early Pregnancy Test.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083188

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel